DDX3X and diffuse large B-cell lymphoma: By comparing the mutation frequency between our study and published papers, we found that SPEN mutation frequency in this study (17%) was higher than that in Western research (1–6%), and the mutation frequency of DDX3X, which was not previously described as mutated in Western DLBCL cases, was 6% in our study (Table S2).